N-acetyl resonances in in vivo and in vitro NMR spectroscopy of cystic ovarian tumors

NMR in Biomedicine

Volumn 22, Issue 10, 2009, Pages 1093-1099

  Kolwijck, Eva ^a   Engelke, Udo F ^a   Van Der Graaf, Marinette ^a   Heerschap, Arend ^a   Blom, Henk J ^a,b   Hadfoune, M'Hamed ^c   Buurman, Wim A ^c   Massuger, Leon F ^a   Wevers, Ron A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

1 acid glycoprotein; 1H NMR spectroscopy; Biomarker; Cyst fluid; Magnetic resonance spectroscopy; N acetyl L aspartic acid; Ovarian tumor

Indexed keywords

CYST FLUIDS; L-ASPARTIC ACID; NMR SPECTROSCOPY; OVARIAN TUMOR;

BIOMARKERS; CARBOXYLIC ACIDS; ELECTRON WAVE TUBES; FLUIDS; GLYCOPROTEINS; LIPIDS; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONCOLOGY; ORGANIC ACIDS; PARTICLE DETECTORS; PROTEINS; TUMORS;

RESONANCE;

ALPHA1 GLYCOPROTEIN; GLYCOLIPID; GLYCOPROTEIN; SIALIC ACID;

ACETYLATION; ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CLINICAL ARTICLE; CORRELATION ANALYSIS; CYST FLUID; FEMALE; FOURIER TRANSFORMATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; OVARY CYST; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PROTON NUCLEAR MAGNETIC RESONANCE;

ADULT; AGED; ASPARTIC ACID; CYST FLUID; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OVARIAN CYSTS; OVARIAN NEOPLASMS; YOUNG ADULT;

EID: 73349096902     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1417     Document Type: Article

References (39)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J. Clin. 2008; 58(2): 71-96.
2. Colombo N, van Gorp T, Parma G, Amant F, Gatta G, Sessa C, Vergote I. Ovarian cancer. Crit. Rev. Oncol. Hematol. 2006; 60(2): 159-179.
3. Kurman RJ. Blaustein's Pathology Of The Female Genital Tract, 5th edn. Springer-Verlag: New York, 2002.
4. Bar JK, Harlozinska A, Sobanska E, Cislo M. Relation between ovarian carcinoma-associated antigens in tumor tissue and detached cyst fluid cells of patients with ovarian neoplasms. Tumori 1994; 80(1): 50-55.
5. Harlozinska A, Bar JK, Jothy S, Sedlaczek P, Slesak B, Richter R. Carcinoembryonic antigen isotypes in tissue sections and loose cyst fluid cells of ovarian neoplasms. Tumour Biol. 1993; 14(1): 1-8.
6. Boss EA, Moolenaar SH, Massuger LF, Boonstra H, Engelke UF, de Jong JG, Wevers RA. High-resolution proton nuclear magnetic resonance spectroscopy of ovarian cyst fluid. NMR Biomed. 2000; 13(5): 297-305.
7. 1H-magnetic resonance spectroscopy: a new technique to discriminate benign from malignant ovarian tumors. Cancer 1998; 82(9): 1726-1730.
8. Hascalik S, Celik O, Sarac K, Meydanli MM, Alkan A,Mizrak B. Metabolic changes in pelvic lesions: findings at proton MR spectroscopic imaging. Gynecol. Obstet. Invest. 2005; 60(3): 121-127.
9. Cho SW, Cho SG, Lee JH, Kim HJ, Lim MK, Kim JH, Suh CH. In-vivo proton magnetic resonance spectroscopy in adnexal lesions. Korean J. Radiol. 2002; 3(2): 105-112.
10. Stanwell P, Russell P, Carter J, Pather S, Heintze S, Mountford C. Evaluation of ovarian tumors by proton magnetic resonance spectroscopy at three Tesla. Invest. Radiol. 2008; 43(10): 745-751.
11. Okada T, Harada M, Matsuzaki K, Nishitani H, Aono T. Evaluation of female intrapelvic tumors by clinical proton MR spectroscopy. J. Magn. Reson. Imaging 2001; 13(6): 912-917.
12. 13C NMR spectroscopy of human blood plasma. Anal. Chem. 1995; 67(5): 793-811.
13. Hochepied T, Berger FG, Baumann H, Libert C. Alpha(1)-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties. Cytokine Growth Factor Rev. 2003; 14(1): 25-34.
14. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann. N. Y. Acad. Sci. 1987; 508: 333-348.
15. Ordidge RJ, Vyver van de FL. Re: Separate water and fat MR images. Radiology 1985; 157(2): 551-553.
16. Ogg RJ, Kingsley PB, Taylor JS. WET, a T1- and B1-insensitive water-suppression method for in vivo localized 1H NMR spectroscopy. J. Magn. Reson. B 1994; 104(1): 1-10.
17. Engelke UF, Kremer B, Kluijtmans LA, van der Graaf M, Morava E, Loupatty FJ, Wanders RJ, Moskau D, Loss S, van den Bergh E, Wevers RA. NMR spectroscopic studies on the late onset form of 3-methylglutaconic aciduria type I and other defects in leucine metabolism. NMR Biomed. 2006; 19(2): 271-278.
18. de Vries J, Thijssen WA, Snels SE, Menovsky T, Peer NG, Lamers KJ. Intraoperative values of S-100 protein, myelin basic protein, lactate, and albumin in the CSF and serum of neurosurgical patients. J Neurol. Neurosurg. Psychiatr. 2001; 71(5): 671-674.
19. Jakobs C, ten Brink HJ, Langelaar SA, Zee T, Stellaard F, Macek M, Srsnova K, Srsen S, Kleijer WJ. Stable isotope dilution analysis of N-acetyl aspartic acid in CSF, blood, urine and amniotic fluid: accurate postnatal diagnosis and the potential for prenatal diagnosis of Canavan disease. J. Inherit. Metab. Dis. 1991; 14(5): 653-660.
20. van Dielen FM, van't Veer C, Schols AM, Soeters PB, Buurman WA, Greve JW. Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals. Int. J. Obes. Relat. Metab. Disord. 2001; 25(12): 1759-1766.
21. de Vries B, Walter SJ, Wolfs TG, Hochepied T, Rabina J, Heeringa P, Parkkinen J, Libert C, Buurman WA. Exogenous alpha-1-acid glycoprotein protects against renal ischemia-reperfusion injury by inhibition of inflammation and apoptosis. Transplantation 2004; 78(8): 1116-1124.
22. Engelke UF, Liebrand-van Sambeek ML, de Jong JG, Leroy JG, Morava E, Smeitink JA, Wevers RA. N-acetylated metabolites in urine: proton nuclear magnetic resonance spectroscopic study on patients with inborn errors of metabolism. Clin. Chem. 2004; 50(1): 58-66.
23. 1H nuclear-magnetic-resonance spectroscopy of sialyl-oligosaccharides from patients with sialidosis (mucolipidosis I and II). Eur. J. Biochem. 1978; 87(2): 323-329.
24. 1H-MRS) for evaluation of human gastric carcinoma. Magn. Reson. Imaging 2004; 22(6): 861-870.
25. Mackinnon WB, Huschtscha L, Dent K, Hancock R, Paraskeva C, Mountford CE. Correlation of cellular differentiation in human colorectal carcinoma and adenoma cell lines with metabolite profiles determined by 1H magnetic resonance spectroscopy. Int. J. Cancer 1994; 59(2): 248-261.
26. Schiebler ML, Miyamoto KK, White M, Maygarden SJ, Mohler JL. In vitro high resolution 1H-spectroscopy of the human prostate: benign prostatic hyperplasia, normal peripheral zone and adenocarcinoma. Magn. Reson. Med. 1993; 29(3): 285-291.
27. Mountford C, Ramadan S, Stanwell P, Malycha P. Proton MRS of the breast in the clinical setting. NMR Biomed. 2009; 22(1): 54-64.
28. Mahon MM, Williams AD, Soutter WP, Cox IJ, McIndoe GA, Coutts GA, Dina R, deSouza NM. 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration. NMR Biomed. 2004; 17(1): 1-9.
29. Mackinnon WB, Russell P, May GL, Mountford CE. Characterization of human ovarian epithelial tumors (ex vivo) by proton magnetic resonance spectroscopy. Int. J. Gynecol. Cancer 1995; 5(3): 211-221.
30. Hascalik S, Celik O, Sarac K, Alkan A, Mizrak B. Clinical significance of N-acetyl-L-aspartate resonance in ovarian mucinous cystadenoma. Int. J. Gynecol. Cancer 2006; 16(1): 423-426.
31. Sibtain NA, Howe FA, Saunders DE. The clinical value of proton magnetic resonance spectroscopy in adult brain tumours. Clin. Radiol. 2007; 62(2): 109-119.
32. Baslow MH. N-acetylaspartate in the vertebrate brain: metabolism and function. Neurochem. Res. 2003; 28(6): 941-953.
33. Baslow MH, Yamada S. Identification of N-acetylaspartate in the lens of the vertebrate eye: a new model for the investigation of the function of N-acetylated amino acids in vertebrates. Exp. Eye Res. 1997; 64(2): 283-286.
34. Burlina AP, Ferrari V, Facci L, Skaper SD, Burlina AB. Mast cells contain large quantities of secretagogue-sensitive N-acetylaspartate. J. Neurochem. 1997; 69(3): 1314-1317.
35. Yang Z, Wu JH, Kuo HW, Kannagi R, Wu AM. Expression of sialyl Lex, sialyl Lea, Lex and Ley glycotopes in secreted human ovarian cyst glycoproteins. Biochimie 2009; 91(3): 423-433.
36. Yanagi K, Ohyama K, Yamakawa T, Watanabe H, Hirakawa S, Ohkuma S. Biochemical characterization of glycoprotein components in human ovarian cyst fluids by lectins. Int. J. Biochem. 1990; 22(6): 659-663.
37. Saldova R, Wormald MR, Dwek RA, Rudd PM. Glycosylation changes on serum glycoproteins in ovarian cancer may contribute to disease pathogenesis. Dis. Markers 2008; 25(4-5): 219-232.
38. Arnold JN, Saldova R, Hamid UM, Rudd PM. Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation. Proteomics 2008; 8(16): 3284-3293.
39. Wu AM, Khoo KH, Yu SY, Yang Z, Kannagi R, Watkins WM. Glycomic mapping of pseudomucinous human ovarian cyst glycoproteins: identification of Lewis and sialyl Lewis glycotopes. Proteomics 2007; 7(20): 3699-3717.